These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32690519)

  • 21. Towards tailoring of self-management for patients with chronic heart failure or chronic obstructive pulmonary disease: a protocol for an individual patient data meta-analysis.
    Jonkman NH; Westland H; Trappenburg JC; Groenwold RH; Effing-Tijdhof TW; Troosters T; van der Palen J; Bourbeau J; Jaarsma T; Hoes AW; Schuurmans MJ
    BMJ Open; 2014 May; 4(5):e005220. PubMed ID: 24860002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transition program for adolescents with congenital heart disease in transition to adulthood: protocol for a mixed-method process evaluation study (the STEPSTONES project).
    Saarijärvi M; Wallin L; Moons P; Gyllensten H; Bratt EL
    BMJ Open; 2019 Aug; 9(8):e028229. PubMed ID: 31377699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flip focus and emphasise patient resources in person-centred care over the telephone-A retrospective descriptive study.
    Ulin K; Fors A; Ali L; Ekman I; Jansson I
    Scand J Caring Sci; 2023 Sep; 37(3):797-804. PubMed ID: 36932728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a minimal home-based psychoeducative intervention versus usual care for managing anxiety and dyspnoea in patients with severe chronic obstructive pulmonary disease: a randomised controlled trial protocol.
    Bove DG; Overgaard D; Lomborg K; Lindhardt BØ; Midtgaard J
    BMJ Open; 2015 Jul; 5(7):e008031. PubMed ID: 26152326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organizational structure for chronic heart failure and chronic obstructive pulmonary disease.
    Rinne ST; Liu CF; Wong ES; Hebert PL; Heidenreich P; Bastian LA; Au DH
    Am J Manag Care; 2016 Mar; 22(3):e82-7. PubMed ID: 26978239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tailored, psychological intervention for anxiety or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): protocol for a randomised controlled trial.
    Sohanpal R; Pinnock H; Steed L; Heslop Marshall K; Chan C; Kelly M; Priebe S; Roberts CM; Singh S; Smuk M; Saqi-Waseem S; Healey A; Underwood M; White P; Warburton C; Taylor SJC;
    Trials; 2020 Jan; 21(1):18. PubMed ID: 31907074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of person-centred care provided to patients with chronic heart failure and/or chronic obstructive pulmonary disease.
    Pirhonen L; Gyllensten H; Olofsson EH; Fors A; Ali L; Ekman I; Bolin K
    Health Policy Open; 2020 Dec; 1():100005. PubMed ID: 37383310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transitional care quality indicators to assess quality of care following hospitalisation for chronic obstructive pulmonary disease and heart failure: a systematic review protocol.
    Michael F; Whitelaw S; Van Spall HG
    BMJ Open; 2019 Dec; 9(12):e032764. PubMed ID: 31892659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Italian Survey on Prevalence and Disease Management of Chronic Heart Failure and Chronic Obstructive Pulmonary Disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design.
    Griffo R; Spanevello A; Temporelli PL; Faggiano P; Carones M; Magni G; Ambrosino N; Tavazzi L;
    Monaldi Arch Chest Dis; 2014 Mar; 82(1):29-34. PubMed ID: 25481938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
    Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
    BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of resistance training description in COPD trials: study protocol for a systematic review.
    Westra B; de Wolf S; Bij de Vaate E; Legemaat M; Nyberg A; Klijn P
    BMJ Open; 2019 Jan; 9(1):e025030. PubMed ID: 30670522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality Assessment of an Integrated Care Pathway Using Telemonitoring in Patients with Chronic Heart Failure and Chronic Obstructive Pulmonary Disease: Protocol for a Quasi-Experimental Study.
    Herkert C; Kraal JJ; Spee RF; Serier A; Graat-Verboom L; Kemps HMC
    JMIR Res Protoc; 2020 Nov; 9(11):e20571. PubMed ID: 33211017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.
    Griffo R; Spanevello A; Temporelli PL; Faggiano P; Carone M; Magni G; Ambrosino N; Tavazzi L;
    Eur J Prev Cardiol; 2017 Apr; 24(6):567-576. PubMed ID: 28067533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A behaviour change intervention to reduce sedentary time in people with chronic obstructive pulmonary disease: protocol for a randomised controlled trial.
    Cheng SWM; Alison J; Dennis S; Stamatakis E; Spencer L; McNamara R; Sims S; McKeough Z
    J Physiother; 2017 Jul; 63(3):182. PubMed ID: 28526329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).
    Kunadian V; Chan D; Ali H; Wilkinson N; Howe N; McColl E; Thornton J; von Wilamowitz-Moellendorff A; Holstein EM; Burns G; Fisher A; Stocken D; De Soyza A;
    BMJ Open; 2018 May; 8(5):e020713. PubMed ID: 29804061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telehealth for patients with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis protocol.
    Gaveikaite V; Fischer C; Schonenberg H; Pauws S; Kitsiou S; Chouvarda I; Maglaveras N; Roca J
    BMJ Open; 2018 Sep; 8(9):e021865. PubMed ID: 30232108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Level of Integration in Integrated Disease Management Leads to Higher Usage in the e-Vita Study: Self-Management of Chronic Obstructive Pulmonary Disease With Web-Based Platforms in a Parallel Cohort Design.
    Talboom-Kamp EP; Verdijk NA; Kasteleyn MJ; Harmans LM; Talboom IJ; Numans ME; Chavannes NH
    J Med Internet Res; 2017 May; 19(5):e185. PubMed ID: 28566268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.